PERCH : PartnERship to Contrast HPV

EU Project Title : EU4H-2021-JA-02: (DP/C-g-08.1.2) Direct grant to Member States’ authorities: support to assist Member States to roll out large-scale human papillomavirus vaccination campaigns Work Programme : EU4Health Type of Action : PJG Budget : 4.750.000,01 € Project duration : 01 November 2022 - 30 April 2025 (30 months) Lead Coordinator : ISS, Italy Contact : Be_EBCP@sciensano.be, Marc Arbyn Website : under construction Domain / Area : Prevention

Main objectives

The aim of this joint action is to contribute to the implementation of Europe’s Beating Cancer Plan, which aims to support Member States’ efforts to extend the roll-out of routine HPV vaccination of girls and boys to eliminate cervical cancer and other cancers caused by HPV in the coming decade.

The joint action will support the exchange of validated best practices between the Member States to ensure a consistent and efficient roll-out of HPV vaccination.

Specific Objectives:

1. To improve evidence on how HPV vaccination and HPV screening are implemented and monitored in all participating countries
2. To improve data and monitoring system on HPV vaccination and HPV screening
3. To improve HPV awareness
4. To improve knowledge and abilities for health professionals in vaccine communication

Consortium

Partners

• 19 Countries
• 34 partners

​Belgian partners

• Sciensano

Structure

• WP1 : Project Management & Coordination (Instituto Superriore di Sanita (ISS) - Italy)
• WP2 : Dissemination (Onkoloski Institut Ljubljana (OI Ljubljana) - Slovenia)
• WP3 : Evaluation (Institut Catala d'Oncologia (ICO) - Spain)
• WP4 : Integration & Sustainability (Sciensano - Belgium)
• WP5 : Monitoring (Sciensano/ICO)
• WP6 : Improving knowledge & awareness to increase vaccin uptake in target communities (ISS/1st Ygeionomiki Perifereia Dype Attikis (1st YPE) - Greece)
• WP7 : Training & support in vaccine communication (Bundeszentrale fur gesundheitliche Aufklarung (BZgA- - Germany)

EBCP Flagships

• F3. Vaccinate at least 90% of girls and a significant increase of boys against human papillomaviruses by 2030 with support from EU funds and investment in infrastructure.

Actions

• A2. Saving lives through sustainable cancer prevention

Link to Cancer Mission / recommendations

• R3: Support the development and implementation of effective cancer prevention strategies and policies within Member States and the EU

Keywords

• HPV
• vaccination coverage 
• cervical cancer